STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Stereotaxis, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $101.03M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.98 (−66.22%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Stereotaxis, Inc. saw revenue fall 5.5% to $30.07M over the twelve months to Jun 30, 2026. Free cash flow was -$15.50M.
Revenue
$30.07M
-5.5% vs. a year earlier
Operating income
-$22.76M
TTM Q2 2026
Free cash flow
-$15.50M
TTM Q2 2026
EPS, diluted
-$0.24
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $101.03M
- P/E ratio
- –
- Price to sales
- 3.36
- Price to book
- 8.25
- Dividend yield
- –
- Free cash flow yield
- -15.34%
Fundamentals
- Revenue
- $30.07M
- Net income
- -$22.32M
- EPS, diluted
- -$0.24
- Free cash flow
- -$15.50M
- Book value per share
- $0.12
- Diluted shares
- 100M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$30.07M-5.5% YoY
Gross profit
$16.71M+4.7% YoY
Operating income
-$22.76M
Net income
-$22.32M
EPS, diluted
-$0.24
Free cash flow
-$15.50M
Reported periodTrailing twelve months